Gore Septal Occluder Clinical Study: A study to evaluate safety and efficacy in the treatment of transcatheter closure of ostium secundum atrial septal defects (ASDs)

To evaluate the safety and efficacy of the GORE Septal Occluder in the treatment of percutaneous, transcatheter closure of ostium secundum atrial septal defects.

September 25, 2015

  • Clinical Trial Information

    Trial Contact: Cowden, Amanda

    Trial Phone: 321.841.5365

  • Age Group: Adult

    Phase: Device: Significant Risk

    Principal Investigator: David Gordon Nykanen, MD

    Sub Investigators:

    IRB No: 12.124.10

    Secondary Protocol No: GSO 10-09

    Applicable Disease Sites: Atrial Septal Defects